A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
- Status
- WITHDRAWN
- Phase
- N/A
Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- NA
Sunitinib to Treat Recurrent Brain Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE2
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Monteris AutoLITTâ„¢ FIM Safety Trial for Recurrent/Progressive Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE2